Angiotensin II regulation of renal vascular ENaC proteins

American Journal of Hypertension

Volumn 22, Issue 6, 2009, Pages 593-597

  Jernigan, Nikki L ^a   Speed, Joshua ^a   Lamarca, Babette ^a   Granger, Joey P ^a   Drummond, Heather A ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN II; EPITHELIAL SODIUM CHANNEL; PHENYLEPHRINE; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; KIDNEY BLOOD VESSEL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; TELEMETRY; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; EPITHELIAL SODIUM CHANNEL; HYPERTENSION, RENOVASCULAR; INFUSIONS, INTRAVENOUS; MALE; MICE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; RENAL ARTERY; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 67349114794     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.59     Document Type: Article

References (21)

1. Snyder PM. Minireview: regulation of epithelial Na+ channel trafficking. Endocrinology 2005; 146:5079-5085.
2. Kellenberger S, Schild L. Epithelial sodium channel/degenerin family of ion channels: a variety of functions for a shared structure. Physiol Rev 2002; 82: 735-767.
3. Drummond HA, Jernigan NL, Grifoni SC. Sensing tension: epithelial sodium channel/acid-sensing ion channel proteins in cardiovascular homeostasis. Hypertension 2008; 51:1265-1271.
4. Drummond HA, Grifoni SC, Jernigan NL. A new trick for an old dogma: ENaC proteins as mechanotransducers in vascular smooth muscle. Physiology (Bethesda) 2008; 23:23-31.
5. Fronius M, Clauss WG. Mechano-sensitivity of ENaC: may the (shear) force be with you. Pflugers Arch 2008; 455:775-785.
6. Folgering JH, Sharif-Naeini R, Dedman A, Patel A, Delmas P, Honoré E. Molecular basis of the mammalian pressure-sensitive ion channels: focus on vascular mechanotransduction. Prog Biophys Mol Biol 2008; 97: 180-195.
7. Griffin KA, Bidani AK. Hypertensive renal damage: insights from animal models and clinical relevance. Curr Hypertens Rep 2004; 6:145-153.
8. Wang X, Ajikobi DO, Salevsky FC, Cupples WA. Impaired myogenic autoregulation in kidneys of Brown Norway rats. Am J Physiol Renal Physiol 2000; 278:F962-F969.
9. Beutler KT, Masilamani S, Turban S, Nielsen J, Brooks HL, Ageloff S, Fenton RA, Packer RK, Knepper MA. Long-term regulation of ENaC expression in kidney by angiotensin II. Hypertension 2003; 41:1143-1150.
10. Jernigan NL, LaMarca B, Speed J, Galmiche L, Granger J P, Drummond HA. Dietary salt enhances benzamil-sensitive component of myogenic constriction in mesenteric arteries. Am J Physiol Heart Circ Physiol 2008; 294:H409-H420.
11. Jernigan NL, Drummond HA. Myogenic vasoconstriction in mouse renal interlobar arteries: role of endogenous β and γENaC. Am J Physiol Renal Physiol 2006; 291:F1184-F1191.
12. Jernigan NL, Drummond HA. Vascular ENaC proteins are required for renal myogenic constriction. Am J Physiol Renal Physiol 2005; 289:F891-F901.
13. Gannon K P, Galmiche L, Drummond H. ASIC2 protein is required for pressure-induced constriction in mouse middle cerebral artery. FASEB J 2007; 21:587-589.
14. Syntichaki P, Tavernarakis N. Genetic models of mechanotransduction: the nematode Caenorhabditis elegans. Physiol Rev 2004; 84:1097-1153.
15. Brooks HL, Allred AJ, Beutler KT, Coffman TM, Knepper MA. Targeted proteomic profiling of renal Na(+) transporter and channel abundances in angiotensin II type 1a receptor knockout mice. Hypertension 2002; 39(2 Pt 2):470-473.
16. Hayashi K, Epstein M, Saruta T. Altered myogenic responsiveness of the renal microvasculature in experimental hypertension. J Hypertens 1996; 14:1387-1401.
17. Wang CT, Chin SY, Navar LG. Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats. Am J Physiol Renal Physiol 2000; 279:F319-F325.
18. Inscho EW, Imig JD, Deichmann PC, Cook AK. Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats. J Am Soc Nephrol 1999; 10(Suppl 11):S178-S183.
19. Casellas D, Bouriquet N, Herizi A. Bosentan prevents preglomerular alterations during angiotensin II hypertension. Hypertension 1997; 30:1613-1620.
20. Inscho EW, Carmines PK, Cook AK, Navar LG. Afferent arteriolar responsiveness to altered perfusion pressure in renal hypertension. Hypertension 1990; 15(6 Pt 2):748-752.
21. Inscho EW, Cook AK, Murzynowski JB, Imig JD. Elevated arterial pressure impairs autoregulation independently of AT(1) receptor activation. J Hypertens 2004; 22:811-818.